Onco-Innovations reports new cancer treatment progress, showing their drug makes radiation more effective in mice.

Onco-Innovations Limited reported promising results from a study showing that their new class of PNKP inhibitors can increase cancer cells' sensitivity to radiation in mice. Conducted by the University of Alberta, the study found that the technology could potentially enhance cancer treatments by making them more effective and reducing side effects. The company also engaged Venture Liquidity Providers Inc. to support market making for its shares.

5 weeks ago
7 Articles